In addition to the CYP1A2 and CYP2D6 variations, a multiple linear regression analysis was performed to estimate the influence of non-genetic factors, sex and age as well as of tobacco smoking, the CYP1A2 inducing factor on olanzapine exposure in patients with psychiatric disorders (Table 3). The gene discussed is CYP1A2; the disease is psychiatric disorder.